Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cipotrex is a **topical dermatologic kit** for the treatment of **plaque psoriasis** that contains **calcipotriene cream 0.005%** together with transparent dressing sheets. The pharmacologically active drug component is **calcipotriene**, a synthetic **vitamin D3 analog** used as a topical antipsoriatic. Calcipotriene modulates keratinocyte proliferation and differentiation through the **vitamin D receptor**, helping normalize the abnormal epidermal growth seen in psoriasis. Cipotrex is marketed in the United States as a prescription topical kit and, according to current labeling, is listed as an **unapproved drug other** product packaged for V2 Pharma.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cipotrex.